feed,title,long_url,short_url
Benzinga,Multiple Sclerosis Drugs Market to Gain US$ 32.7 billion Revenue with 3.5% CAGR by 2030 | Growth Plus Reports,https://benzinga.com/pressreleases/22/11/g29764246/multiple-sclerosis-drugs-market-to-gain-us-32-7-billion-revenue-with-3-5-cagr-by-2030-growth-plus-,
Benzinga,Global Biphenyl Market to Reach $1.98 Billion by 2031 at a CAGR of 4.8%,https://benzinga.com/pressreleases/22/11/g29764232/global-biphenyl-market-to-reach-1-98-billion-by-2031-at-a-cagr-of-4-8,
